Defective Differentiation of Myeloid and Plasmacytoid Dendritic Cells in Advanced Cancer Patients is not Normalized by Tyrosine Kinase Inhibition of the Vascular Endothelial Growth Factor Receptor - T. D. de Gruijl; G. Giaccone; R. J. Scheper; H. van Cruijsen; K. Hoekman; B. C. Kuenen; A. J. M. van den Eertwegh; A. G. M. Stam (Clinical and Developmental Immunology)